11 – 20 of 135
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Polygenic risk in Type III hyperlipidaemia and risk of cardiovascular disease : An epidemiological study in UK Biobank and Oxford Biobank
(
- Contribution to journal › Article
-
Mark
Syncope in hypertrophic cardiomyopathy (part II) : An expert consensus statement on the diagnosis and management
(
- Contribution to journal › Article
-
Mark
Organizational and patient-level predictors for attaining key risk factor targets in cardiac rehabilitation after myocardial infarction : The Perfect-CR study
(
- Contribution to journal › Article
-
Mark
Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function
(
- Contribution to journal › Article
-
Mark
Platelet mitochondrial DNA methylation : A novel biomarker for myocardial infarction – A preliminary study
2023) In International Journal of Cardiology(
- Contribution to journal › Article
- 2022
-
Mark
The Authors' Reply to the Letter “Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis”
(
- Contribution to journal › Letter
-
Mark
Major adverse cardiovascular events following acute coronary syndrome in patients with bipolar disorder
(
- Contribution to journal › Article
-
Mark
Factors influencing kinesiophobia during the “blanking period” after radiofrequency catheter ablation in patients with atrial fibrillation by the fear-avoidance model
(
- Contribution to journal › Article
-
Mark
Transradial versus trans-femoral access site in high-speed rotational atherectomy in Sweden
(
- Contribution to journal › Article
-
Mark
Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction : The phase 2a FLAVOUR study
(
- Contribution to journal › Article